Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities
CA 2343133 A1 · Owner: Zasloff, Michael · Inventors: Williams, Jon; Zasloff, Michael; Sokoloff, Mitchell H.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method for treating a tumor includes a first treatment procedure using a conventional cancer treatment technique and a second treatment procedure , which includes administering an effective amount of squalamine. Synergistically effective amounts are preferred. The first treatment procedure may be a treatment with one or more conventional cytotoxic chemical compounds. As examples, the cytotoxic chemical compound may be a nitrosourea (such as BCNU), cyclophosphamide, doxorubicin, 5-fluorouracil paclitaxel and its , derivatives, cisplatin or other platinum containing cancer treating agents. Alternatively, the first treatment may be a treatment with one or more conventional …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 10, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 10, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 10, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.